Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients (DAFNE)

Astellas

Status: Completed

Conditions: Clostridium Difficile Infection

Treatments: Drug: Fidaxomicin; Drug: Treatment for CDI other than fidaxomicin Type

Study type: Observational

Funder types: Industry

Identifiers

NCT02214771

FR-FID-NI-001

Details and patient eligibility

About

The study aims to describe the characteristics and the methods of management and follow-up of patients treated with fidaxomicin for Clostridium difficile infection (CDI).

Enrollment: 296 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Hospitalized patient
• Patient diagnosed with CDI

Exclusion criteria

• Patient already included in this study
• Patient is taking part in a clinical trial in the field of CDI

Trial design

296 participants in 2 patient groups

1: CDI in patients treated with fidaxomicin

Description:

Diagnosed with a CDI and treated with fidaxomicin

Treatment:

Drug: Fidaxomicin

2: CDI in patients receiving treatment other than fidaxomicin

Description:

Diagnosed with a CDI, regardless of the prescribed treatment (not fidaxomicin)

Treatment:

Drug: Treatment for CDI other than fidaxomicin Type